Reported May 20, 2015 · Terminated

Ortho-Cept (0.15 mg desogestrel and 0.03 mg ethinyl estradiol) tablets, 28- count blister (21 active tablets and 7…

Janssen Pharmaceuticals, Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Janssen Pharmaceuticals, Inc. · 1125 Trenton-Harbourton Rd · Titusville, NJ · 08560-1503

Is this the product you have?

  • Ortho-Cept (0.15 mg desogestrel and 0.03 mg ethinyl estradiol) tablets, 28- count blister (21 active tablets and 7 placebo tablets)/ 6 blister packs per carton. Rx only
  • Jointly Manufactured byJanssen Ortho, LLC, Manati, Puerto Rico 00674 and NV Organon, Oss, The Netherlands
  • Manufactured forJanssen Pharmaceuticals, Inc., Titusville, New Jersey 08560, New Jersey, NDC 50458-0196-15
Lot codes and dates
    • Lot # 13CM724
    • Exp.09/15 (US) Lot # (L) 13DM732
    • Exp. 09/15 (Canada)
Amount recalled
16,861 cartons/6 blister units (28 tablets) each

Where it was sold

  • Nationwide

Why it was recalled

Subpotent Drug

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Janssen Pharmaceuticals, Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Jul 13, 2018 · Data as of Sep 19, 7:17 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.